CBD Capsules contain full spectrum CBD oil 6% in organic sesame seed oil, 40+ terpenes and flavonoids.
CBD/CBDA: 30mg/capsule
Total content CBD/CBDA is 900+mg per box.
Terpenes: 22,67mg/g
Packaging: 30 cps/box
Suitable for all diets and religions, 100% plant based.
Manufactured by Pharmaceutical EU GMP and FDA certified factory.
Certification is available on request.
Under Novel Food registration process by EFSA*.
The product is registered by the Australian Government, Department of Health, Therapeutic Goods Administration (TGA).
CBD capsules contain full spectrum CBD oil 6% in organic sesame seed oil, 40+ terpenes and flavonoids. The capsules contain also daily dose of vitamins C, B2, B6 and D in micropellets.
Vitamin C contributes to the normal function of the nervous system.
Vitamin B2 helps protect cells from oxidative stress.
Vitamin B6 contributes to reducing fatigue and exhaustion.
Vitamin D contributes to the normal function of the Immune system.
CBD/CBDA: 20mg/capsule + vitamins C, B2, B6 and D in a daily dose.
Total content CBD/CBDA is 600mg per box.
Terpenes: 22,67mg/g
Packaging: 30 cps/box
Suitable for all diets and religions, 100% plant based.
Manufactured by Pharmaceutical EU GMP and FDA certified factory.
Certification is available on request.
Under Novel Food registration process by EFSA*.
The product is registered by the Australian Government, Department of Health, Therapeutic Goods Administration (TGA).
New unique formulation of CBD capsules contains full spectrum CBD oil 6% in organic sesame seed oil, 40+ terpenes and flavonoids and Mint Oil.
Contributes to the normal Intestinal and Digestive Function
Contributes to the normal Gall Bladder Function
Contributes to the normal Liver Function
Contributes to the natural function of the Immune system
CBD/CBDA: 20mg/cps + Mint Oil 150mg/cps
Total content CBD/CBDA is 600mg per box.
Terpenes: 22,67mg/g
Packaging: 30 cps/box
Suitable for all diets and religions, 100% plant based.
Manufactured by Pharmaceutical EU GMP and FDA certified factory.
Certification is available on request.
Under Novel Food registration process by EFSA*.
The product is registered by the Australian Government, Department of Health, Therapeutic Goods Administration (TGA).
CBD capsules with innovative UC-II®, undenatured type II collagen
and vitamins C, K2 & D.
This is an innovative formulation to maintain life-time joint mobility.
Contributes to the maintenance of normal bones and the normal formation of connective tissue and collagen.
Active ingredients
cps
RDD*
Canabidiol
20mg
NA
Undenaturated Type II Collagen (UC-II®, Lonza®)
40mg
NA
Vitamin C
12mg
15%
Vitamin K2Vital (Kaqpa®)
75μg
100%
Vitamin D
5μg
100%
*RDD-Recomended Daily Dose
CBD: 20mg/capsule.
Total content CBD is 600mg per box.
Manufactured by Pharmaceutical EU GMP and FDA certified factory.
Certification is available on request.
Under Novel Food registration process by EFSA*.
The product is registered by the Australian Government, Department of Health, Therapeutic Goods Administration (TGA).
Based on Lonza, Pfizer and Kapqa® Bioscience research.
UC-II® is undenatured (native) type II collagen derived from chicken sternum cartilage by Lonza.®
• Trademarked, patented, scientifically studied ingredient for joints
• Small dose (40mg/once per day)
• Unique mechanism of action (Oral tolerance)
• Backed up by science
CBD vegan lozenges contain full spectrum CBD oil 6% in organic sesame seed oil, 40+ terpenes and flavonoids. The lozenges contain also vitamin C.
Vitamin C contributes to the natural function of the immune system and to protect cells from the oxidative stress.
CBD/CBDA: 5mg/lozenge, packaging contains 6 or 12 lozenges.
Total content CBD/CBDA is 30mg or 60mg per box
Packaging: 6 or 12 lozenges/box
Dosage: 1-6 lozenges/day (let it dissolve in your mouth each 2-3 hours).
Manufactured by Pharmaceutical EU GMP and FDA certified company.
Certification is available on request.
Under Novel Food registration process by EFSA.
* In November 2015, the European Parliament and the Council of the European Union adopted a new regulation on Novel Food, Regulation (EU) 2015/2283, with the intent of making the Novel Food authorization process more efficient while ensuring high standards of food safety or consumers. This new Regulation came into force on 1 January 2018. If lawfully marketed in the EU after 15 May 1997, existing Food Supplement products with Cannabidiol and/or Cannabis Sativa Extract can remain on the market as long as an application for Novel Food authorization is submitted to the European Commission before 1 January 2019.
Are you more than 18 years of age?Please verify your age to view the content.
Our website processes cookies in order to increase the user-friendliness of the website and, in the case of your consent, to personalize ads. More infoclose
